Arteriosclerosis Obliterans Clinical Trial
Official title:
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
The goal of this study is to evaluate the possible preoperative predictive value of altered heart rate variability (HRV) and baroreflex sensitivity in different sleep stages for postoperative adverse cardiac events (i.e. arrhythmia or myocardial ischemia needing hospitalization or medication, myocardial ischemia assessed by enzyme release, myocardial infarction, sudden cardiac death, stroke) in arteriosclerosis obliterans patients.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00823849 -
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
|
Phase 4 | |
| Recruiting |
NCT00912756 -
Sufficient Treatment of Peripheral Intervention by Cilostazol
|
Phase 4 | |
| Enrolling by invitation |
NCT02864654 -
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
|
Phase 1/Phase 2 | |
| Completed |
NCT05083299 -
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
|
||
| Active, not recruiting |
NCT02431234 -
Arterial Calcification in the Diabetes
|
||
| Completed |
NCT01518205 -
HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)
|
N/A | |
| Recruiting |
NCT02877173 -
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
|
Phase 2 | |
| Recruiting |
NCT00145262 -
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
|
Phase 2 |